Share-based Payment Arrangement, Expense in USD of Vanda Pharmaceuticals Inc. from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2010 to Q3 2025.
  • Vanda Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2.11M, a 29.6% decline year-over-year.
  • Vanda Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $10.1M, a 21.7% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2024 was $12.4M, a 11.5% decline from 2023.
  • Vanda Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14M, a 13.8% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.3M, a 5.89% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Vanda Pharmaceuticals Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $10.1M $2.11M -$887K -29.6% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $10.9M $2.11M -$880K -29.5% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025
Q1 2025 $11.8M $2.97M -$613K -17.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $12.4M $2.86M -$410K -12.5% 01 Oct 2024 31 Dec 2024 10-K 14 Feb 2025
Q3 2024 $12.8M $3M -$168K -5.31% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $13M $2.99M -$263K -8.1% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025
Q1 2024 $13.3M $3.58M -$767K -17.6% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 $14M $3.27M -$510K -13.5% 01 Oct 2023 31 Dec 2023 10-K 14 Feb 2025
Q3 2023 $14.6M $3.17M -$721K -18.5% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $15.3M $3.25M -$581K -15.2% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024
Q1 2023 $15.9M $4.35M -$427K -8.94% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $16.3M $3.78M +$9K +0.24% 01 Oct 2022 31 Dec 2022 10-K 14 Feb 2025
Q3 2022 $16.3M $3.89M -$63K -1.6% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $16.3M $3.83M +$90K +2.41% 01 Apr 2022 30 Jun 2022 10-Q 28 Jul 2023
Q1 2022 $16.2M $4.78M +$869K +22.2% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023
Q4 2021 $15.4M $3.77M +$562K +17.5% 01 Oct 2021 31 Dec 2021 10-K 08 Feb 2024
Q3 2021 $14.8M $3.95M +$816K +26% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $14M $3.74M +$671K +21.9% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $13.3M $3.91M -$35K -0.89% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q4 2020 $13.4M $3.21M -$456K -12.4% 01 Oct 2020 31 Dec 2020 10-K 09 Feb 2023
Q3 2020 $13.8M $3.14M -$272K -7.98% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $14.1M $3.07M -$32K -1.03% 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021
Q1 2020 $14.1M $3.94M +$662K +20.2% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $13.5M $3.67M +$746K +25.5% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022
Q3 2019 $12.7M $3.41M +$535K +18.6% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020
Q2 2019 $12.2M $3.1M +$380K +14% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 $11.8M $3.28M +$131K +4.16% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 $11.7M $2.92M +$140K +5.03% 01 Oct 2018 31 Dec 2018 10-K 11 Feb 2021
Q3 2018 $11.5M $2.87M +$101K +3.65% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019
Q2 2018 $11.4M $2.72M +$65K +2.45% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019
Q1 2018 $11.4M $3.15M +$895K +39.7% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019
Q4 2017 $10.5M $2.78M +$679K +32.3% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020
Q3 2017 $9.79M $2.77M +$671K +32% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018
Q2 2017 $9.12M $2.66M +$582K +28.1% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018
Q1 2017 $8.53M $2.26M -$10K -0.44% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018
Q4 2016 $8.54M $2.1M +$216K +11.4% 01 Oct 2016 31 Dec 2016 10-K 19 Feb 2019
Q3 2016 $8.33M $2.1M +$39K +1.89% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017
Q2 2016 $8.29M $2.07M +$6K +0.29% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017
Q1 2016 $8.28M $2.27M +$321K +16.5% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017
Q4 2015 $7.96M $1.89M +$217K +13% 01 Oct 2015 31 Dec 2015 10-K 15 Feb 2018
Q3 2015 $7.74M $2.06M +$650K +46.1% 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016
Q2 2015 $7.09M $2.07M +$625K +43.3% 01 Apr 2015 30 Jun 2015 10-Q 28 Jul 2016
Q1 2015 $6.47M $1.95M +$591K +43.6% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016
Q4 2014 $5.88M $1.67M +$213K +14.6% 01 Oct 2014 31 Dec 2014 10-K 17 Feb 2017
Q3 2014 $5.67M $1.41M -$125K -8.14% 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015
Q2 2014 $5.79M $1.44M +$336K +30.4% 01 Apr 2014 30 Jun 2014 10-Q 31 Jul 2015
Q1 2014 $5.45M $1.35M +$50K +3.83% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015
Q4 2013 $5.4M $1.46M -$414K -22.1% 01 Oct 2013 31 Dec 2013 10-K 12 Feb 2016
Q3 2013 $5.82M $1.54M +$960K +167% 01 Jul 2013 30 Sep 2013 10-Q 27 Oct 2014
Q2 2013 $4.86M $1.11M -$81K -6.82% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014
Q1 2013 $4.94M $1.3M -$87K -6.25% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014
Q4 2012 $5.03M $1.87M 01 Oct 2012 31 Dec 2012 10-K 13 Mar 2015
Q3 2012 $576K -$686K -54.4% 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013
Q2 2012 $1.19M -$126K -9.59% 01 Apr 2012 30 Jun 2012 10-Q 31 Jul 2013
Q1 2012 $1.39M 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q3 2011 $1.26M 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012
Q2 2011 $1.31M 01 Apr 2011 30 Jun 2011 10-Q 03 Aug 2012

Vanda Pharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.4M -$1.61M -11.5% 01 Jan 2024 31 Dec 2024 10-K 14 Feb 2025
2023 $14M -$2.24M -13.8% 01 Jan 2023 31 Dec 2023 10-K 14 Feb 2025
2022 $16.3M +$905K +5.89% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025
2021 $15.4M +$2.01M +15.1% 01 Jan 2021 31 Dec 2021 10-K 08 Feb 2024
2020 $13.4M -$98K -0.73% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023
2019 $13.5M +$1.79M +15.4% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022
2018 $11.7M +$1.2M +11.5% 01 Jan 2018 31 Dec 2018 10-K 11 Feb 2021
2017 $10.5M +$1.92M +22.5% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 $8.54M +$582K +7.31% 01 Jan 2016 31 Dec 2016 10-K 19 Feb 2019
2015 $7.96M +$2.08M +35.4% 01 Jan 2015 31 Dec 2015 10-K 15 Feb 2018
2014 $5.88M +$474K +8.77% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017
2013 $5.4M +$378K +7.52% 01 Jan 2013 31 Dec 2013 10-K 12 Feb 2016
2012 $5.03M -$460K -8.39% 01 Jan 2012 31 Dec 2012 10-K 13 Mar 2015
2011 $5.49M +$679K +14.1% 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014
2010 $4.81M 01 Jan 2010 31 Dec 2010 10-K 26 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.